All Supplements
    Supplement

    Lithium Orotate (Low-Dose)New

    Supplement
    Minerals
    3/10 Evidence

    A trace-mineral salt of lithium taken at microdose levels (roughly 1–10 mg of elemental lithium per day) — two to three orders of magnitude below prescription psychiatric lithium carbonate (300–1,200+ mg/day, targeting serum levels of 0.6–1.2 mmol/L for bipolar disorder). It is sold over the counter and marketed as distinct from psychiatric lithium, without the serum monitoring prescription lithium requires. Interest accelerated sharply after an August 2025 Nature paper from the Yankner laboratory at Harvard Medical School reported that brain lithium depletion is among the earliest molecular changes preceding Alzheimer's disease in human tissue, and that lithium orotate — uniquely among 16 lithium salts tested — reversed Alzheimer's-like pathology in aged and AD-model mice.

    Mechanism of Action

    At microdose levels, lithium is proposed to function as an essential trace element — supported by decades of ecological studies linking higher lithium concentrations in municipal drinking water to lower population-level rates of suicide and dementia — rather than as the GSK-3β-inhibiting psychiatric agent it is at therapeutic doses. The 2025 Nature study (Aron, Yankner et al.) found that lithium normally concentrates in the brain and is abnormally sequestered by amyloid-beta plaques in Alzheimer's tissue, depleting the lithium available to neurons and glia. Of the lithium salts tested in mice, lithium orotate uniquely evaded this plaque sequestration, restored neuronal and glial gene expression, reduced amyloid and tau pathology, and improved synaptic and cognitive measures.

    Dosing Protocol

    Recommended

    5–10mg elemental lithium

    Standard starting dose based on research

    Therapeutic Range

    1

    Minimum

    to

    10

    Maximum

    mg elemental lithium

    Once daily with food to reduce gastrointestinal upset; typically taken long-term given its proposed role as a trace nutrient rather than an acute-effect agent

    Cycling Protocol

    No validated cycling protocol exists; given the absence of dedicated human dose-ranging or long-term safety trials at these microdoses, periodic physician reassessment is prudent rather than indefinite unsupervised use

    Dosages are general guidelines. Individual requirements vary based on body weight, health status, and specific goals. Start with lower doses and adjust based on response.

    Benefits

    Primary Benefits

    • A landmark 2025 Nature study (Aron, Ngian, Yankner et al., Harvard Medical School) found brain lithium depletion is among the earliest molecular changes preceding Alzheimer's disease in human autopsy tissue, and that lithium orotate specifically reversed Alzheimer's-like pathology in mice — this is currently human-tissue and animal-model evidence, not a demonstrated clinical benefit in living humans
    • Decades of ecological studies associate higher lithium levels in drinking water with lower population-level suicide and dementia rates — observational data that cannot establish causation
    • Microdose approaches (1–10 mg elemental lithium/day) sit far below psychiatric dosing and are not expected to require serum monitoring, though this has not been formally validated in a dedicated lithium orotate human trial

    Secondary Benefits

    Explored anecdotally for mood stability and stress resilience at sub-psychiatric doses, with limited controlled human data
    Long-standing epidemiological interest in lithium as a possible essential trace nutrient

    Safety Information

    Contraindications

    Do not use if any of the following apply:

    • Significant kidney disease — lithium is renally cleared and low-dose safety in chronic kidney disease is not established
    • Thyroid disease — lithium can affect thyroid function even at low doses with chronic use
    • Pregnancy — lithium at psychiatric doses is associated with fetal cardiac risk (e.g., Ebstein's anomaly); avoid given the lack of safety data at any dose in pregnancy
    • Concurrent prescription lithium therapy — risk of additive toxicity; requires physician supervision

    Drug/Supplement Interactions

    May interact with the following. Consult a healthcare provider before combining:

    Do not combine with prescription lithium (carbonate or citrate) without physician oversight — additive lithium load
    NSAIDs, ACE inhibitors, ARBs, and thiazide diuretics can raise lithium levels by reducing renal clearance — clinically meaningful even at low doses in patients on these medications
    Caution with other nephrotoxic or thyroid-affecting medications, given lithium's renal and thyroid effects at higher or chronic exposure

    Potential Side Effects

    Some users may experience:

    Generally well tolerated at microdose in anecdotal and observational use; formal human safety trials of lithium orotate specifically are lacking
    Mild gastrointestinal upset is possible
    Periodic thyroid and renal function monitoring is reasonable with chronic use, extrapolating from psychiatric-dose lithium safety data

    This is not a complete list of interactions or side effects. Individual responses vary. Always start with the lowest effective dose and monitor your response. Report any adverse effects to your healthcare provider.

    Quality Markers

    Look for these specific quality indicators when sourcing this compound:

    • Confirm elemental lithium content per capsule — lithium orotate is only around 5% elemental lithium by weight, so a '120 mg lithium orotate' capsule contains roughly 5–6 mg of elemental lithium, not 120 mg
    • Third-party certificate of analysis (COA) for identity and heavy metals — purity varies across manufacturers of this lightly regulated ingredient
    • Discuss with a physician before starting, especially if taking any interacting medication listed above

    Trusted Certifications

    NSF Certified
    USP Verified
    GMP Certified
    ConsumerLab Approved

    Note: Supplement quality varies dramatically between brands. Cheap supplements often contain fillers, incorrect doses, or contaminants. Investing in quality products from reputable manufacturers is essential for safety and efficacy.

    Evidence Profile

    Evidence Score

    3/10

    Emerging/Anecdotal

    Limited clinical data, primarily mechanistic studies or user reports

    Classification:
    Emerging — strong 2025 human-tissue and mouse-model mechanistic rationale specific to lithium orotate; no completed human RCT of lithium orotate exists. A March 2026 JAMA Neurology trial (LATTICE) tested a different salt (lithium carbonate, psychiatric-adjacent dosing targeting 0.6–0.8 mmol/L) in mild cognitive impairment and found no benefit on any of 6 co-primary endpoints (cognition, brain volume, BDNF), though it confirmed low-dose lithium's safety over two years. Evidence

    Evidence Scale

    8-10

    Strong

    5-7

    Moderate

    1-4

    Emerging

    PHS
    671
    / 1000
    T3
    Longevity Operator

    Sample member

    Longevity Operator

    The Peak Human Score · PHS v1

    One number for your longevity journey.

    FICO for credit. PHS for longevity. Eight biological domains collapsed into one provable score — intuitive at a glance, rigorous underneath.

    • Metabolic
    • Hormonal
    • Cardiovascular
    • Brain / Cognitive
    • Sleep
    • Musculoskeletal
    • Gut
    • Immunity / Inflammation